Our regulatory experts implement regulatory strategies right from the start to help mitigate risks to improve the probability of success. From early product development to clinical and commercialization, we're here to guide you through every stage. Learn more: https://lnkd.in/e_aw8eK6. #ElevateBio #Innovation
ElevateBio
Biotechnology Research
Waltham, Massachusetts 34,932 followers
A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.
About us
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics. ElevateBio aims to be the dominant engine inside the world’s greatest scientific advancements harnessing human cells and genes to alter disease.
- Website
-
https://www.elevate.bio/
External link for ElevateBio
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Privately Held
- Specialties
- cell therapy, gene therapy, and cell and gene therapy
Locations
-
Primary
Get directions
200 Smith St
Waltham, Massachusetts 02451, US
Employees at ElevateBio
Updates
-
Hear what Kelsey Lakeman, Senior Manager, Business Development Operations, enjoys most about working for a company focused on advancing transformative genetic medicines.
-
-
We’re here to enable your vision right from the start. Our deep understanding of global regulatory requirements make us the perfect partner. From discovery, including vector design through clinical development support, our experts are here to support you at any stage of your journey. Let our expertise be your guide. Learn more at https://lnkd.in/e_aw8eK6.
-
-
LentiPeak – our serum-free, suspension-based, scalable production platform with a demonstrated high volumetric productivity of therapeutically relevant vector yields that meet regulatory guidelines. LentiPeak enables the production of life-changing cell and gene therapies from the preclinical stage through clinical development and commercialization while accelerating timelines and reducing manufacturing costs. Learn how LentiPeak can bring your vision to life: https://lnkd.in/ed8fRD-F.
-
-
We're attending the ASAP BioPharma Conference! Join Hélène Svahnqvist MBA for the Ask an Expert/Mentoring session on Nov 5 at 4:50pm. Register here: https://lnkd.in/eAAZDrTm #ASAPBioPharma #AllianceManagement #BioTech #ProfessionalDevelopment
-
-
We're thrilled to announce Amy Pooler as our SVP, Research and Development. Amy joins our team with over 20 years of scientific leadership and expertise with an extensive background in genetic medicine, drug development, and scientific strategy. Read the full press release here: https://lnkd.in/eAv6xPZH.
-
We're attending the Huntington Study Group's Annual Meeting. Join Logan Brown, Senior Scientist, Gene Editing Vector Core at the Innovators Forum for "Allele-selective editing of mHTT utilizing AAV5-delivered Life Edit CRISPR System (LETI-101) results in meaningful reduction of mHTT protein" on Nov 7. See you there! #HSG2024 #HuntingtonStudyGroup
-
-
We are in search of motivated individuals to join our team at ElevateBio. Take part in our undying passion for constant discovery, new technology, and progress toward life-transforming therapies for patients in need. Sound like a fit? Check out our career openings at elevate.bio/about/careers/. #ElevateBio #Careers #NowHiring
-
-
Base editing enables precise nucleotide-level correction of harmful mutations or disruption of coding sequences to reduce gene expression. Life Edit Therapeutics's base editing systems include A and C base editors for 𝘦𝘹 𝘷𝘪𝘷𝘰 and 𝘪𝘯 𝘷𝘪𝘷𝘰 applications with demonstrated multiplex editing capabilities. Learn more at: https://lnkd.in/e8PRHJnj. #BaseEditing #GeneEditing #ElevateBio
-
-
We hosted Abata Therapeutics for a fireside chat and Q&A with their CEO, Samantha Singer, and COO, John Trzupek. ElevateBio Basecamp has been a long-time partner with Abata, collaborating to accelerate the development of their cell therapy program for multiple sclerosis (MS). The learnings from our partnership and the ABA-101 manufacturing process also serve as a template to benefit future development programs, including their investigational program for Type 1 diabetes. #Innovation #Partnership #TransformativeTherapies
-